Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Fosun Says its M&A/Operating Strategy Designed to Meet Next-Gen Business World

publication date: Apr 4, 2017
In an annual letter to shareholders, China conglomerate Fosun International, the parent of Fosun Pharma, said its heavy use of M&A is designed to promote two linked goals: C2M and a closed loop. C2M (customer-to-maker) describes the internet world that has, in many cases, done away with intermediaries, allowing customers to talk directly to companies -- and vice-versa with targeted advertising. The closed loop is a result of C2M, allowing a company to dominate the varied stages of a particular industry. It is especially evident in healthcare. For Fosun, the closed loop includes health insurance, health management, healthcare delivery, pharmaceutical drugs and medical devices. Fosun is active in each segment. More details....

Stock Symbols: (HK: 0656) (SHA: 600196; HK: 2196)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital